YAKIMA VALLEY MEMORIAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $813K
- Transactions
- 211
- Companies
- 22
- Average per transaction
- $3,852
Who reported the payments
| Merck | $323,249 |
| Acerta Pharma LLC | $142,741 |
| Takeda Pharmaceuticals U.S.A., Inc. | $63,896 |
| Incyte Corporation | $61,018 |
| Amgen | $42,365 |
| Genentech, Inc. | $38,187 |
| Leica Microsystems Inc. | $34,884 |
| E.r. Squibb & Sons, L.L.C. | $20,300 |
| AbbVie | $17,082 |
| Pharmacyclics LLC, An Abbvie Company | $16,247 |
| Gilead | $11,622 |
| Regeneron | $9,800 |
| Genmab A/s | $9,301 |
| Linvatec Corporation | $9,266 |
| Stryker | $5,230 |
| Siemens Medical Solutions USA, Inc. | $2,588 |
| Organon | $2,399 |
| AstraZeneca | $2,365 |
| Epizyme, Inc. | $113 |
| Medline Industries LP | $52 |
| Life Technologies Corporation | $42 |
| Johnson & Johnson | $26 |